Results 161 to 170 of about 42,337 (292)

Lichenoid graft‐versus‐host disease shows a high interferon score, with IFNAR1 inhibition preventing skin inflammation

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study identifies interferons as key mediators in lichenoid chronic GVHD pathogenesis, along with Th2 and Th17 involvement. It particularly highlights the role of Type I interferon, showing that early anti‐IFNAR1 treatment reduces skin inflammation in a murine model of chronic cutaneous GVHD.
Chloé Grolleau, Thomas Poisot, Andreea Calugareanu, Regis Peffault De Latour, Marie Robin, David Michonneau, Flore Sicre de Fontbrune, Adèle de Masson, Maxime Battistella, Gerard Socié, Hélène Le Buanec, Jean‐David Bouaziz   +11 more
wiley   +1 more source

Diagnosis of myelodysplastic syndromes: the classic and the novel. [PDF]

Haematologica
Oster HS, Van de Loosdrecht AA, Mittelman M.   +2 more
europepmc   +1 more source

A Case with Membranous Glomerulonephritis and Myelodysplastic Syndrome

, 1992
S. Paydaş, Semra Paydaş, I Tuncer, Suzan Zorludemir, Gülfiliz Gönlüşen   +4 more
openalex   +1 more source

Anaesthetic management of Caesarean section in a patient with Myelodysplastic Syndrome [PDF]

, 1998
K. Hara, Yoji Saito, Noriko Morimoto, Shinichi Sakura, Yoshihiro Kosaka   +4 more
openalex   +1 more source

Gaucher disease, state of the art and perspectives

Journal of Internal Medicine, EarlyView.
Abstract Knowledge about Gaucher disease (GD), considered a model for rare diseases, has considerably increased since its discovery. The pathophysiology of this lysosomal disorder is better known, and specific therapies that can control many aspects of the disease have been developed, particularly for the most common form, Type 1 GD.
Fabrice Camou, Marc G. Berger
wiley   +1 more source

Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes- a retrospective matched-pairs analysis. [PDF]

Ann Hematol
Rauhe KA, Kasprzak A, Schulz F, Nachtkamp K, Strupp C, Kündgen A, Dietrich S, Mayer K, Götze KS, Hofmann WK, Giagounidis A, Gattermann N, Germing U.   +12 more
europepmc   +1 more source

Alternative Splicing Regulation in Metabolic Disorders

Obesity Reviews, EarlyView.
ABSTRACT Alternative splicing (AS) is a fundamental mechanism for enhancing transcriptome diversity and regulating gene expression, crucial for various cellular processes and the development of complex traits. This review examines the role of AS in metabolic disorders, including obesity, weight loss, dyslipidemias, and metabolic syndrome.
Dorota Kaminska
wiley   +1 more source

Research progress on ferroptosis in Myelodysplastic syndromes. [PDF]

Front Pharmacol
Yang Y, Han J, Wei Y, Jin J, Feng W.
europepmc   +1 more source

International Prognostic Scoring System and Other Prognostic Systems for Myelodysplastic Syndromes [PDF]

, 1997
Carlo L. Balduini, Roberta Guarnone, Alessandro Pecci, Esther Centenara, Edoardo Ascari   +4 more
openalex   +1 more source

Effect of Antibiotics With Anaerobic Coverage on Graft‐Versus‐Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta‐Analysis

Transplant Infectious Disease, EarlyView.
ABSTRACT Background Broad‐spectrum antibiotics are standard for febrile neutropenia (FN) in allogeneic hematopoietic stem cell transplantation (HSCT) but may disrupt gut microbiota, increasing the risk of graft‐versus‐host disease (GVHD). However, current evidence on the effects of anaerobic versus limited anaerobic antibiotic coverage on GVHD‐related
Hiroshi Ito, Yui Okamura, Yuna Tomura, Jura Oshida, Minori Fujita, Daiki Kobayashi   +5 more
wiley   +1 more source